PL375603A1 - Kompozycje porcji leku o przedłużonym działaniu wpostaci zawiesiny z aryloheterocyklicznymi środkami czynnymi - Google Patents

Kompozycje porcji leku o przedłużonym działaniu wpostaci zawiesiny z aryloheterocyklicznymi środkami czynnymi

Info

Publication number
PL375603A1
PL375603A1 PL03375603A PL37560303A PL375603A1 PL 375603 A1 PL375603 A1 PL 375603A1 PL 03375603 A PL03375603 A PL 03375603A PL 37560303 A PL37560303 A PL 37560303A PL 375603 A1 PL375603 A1 PL 375603A1
Authority
PL
Poland
Prior art keywords
arylheterocyclic
suspension
active agents
depot formulations
depot
Prior art date
Application number
PL03375603A
Other languages
English (en)
Inventor
Jaymin Chandrakant Shah
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of PL375603A1 publication Critical patent/PL375603A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL03375603A 2002-10-25 2003-10-13 Kompozycje porcji leku o przedłużonym działaniu wpostaci zawiesiny z aryloheterocyklicznymi środkami czynnymi PL375603A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42129502P 2002-10-25 2002-10-25

Publications (1)

Publication Number Publication Date
PL375603A1 true PL375603A1 (pl) 2005-12-12

Family

ID=32176696

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375603A PL375603A1 (pl) 2002-10-25 2003-10-13 Kompozycje porcji leku o przedłużonym działaniu wpostaci zawiesiny z aryloheterocyklicznymi środkami czynnymi

Country Status (21)

Country Link
US (1) US20040146562A1 (pl)
EP (1) EP1562546A1 (pl)
JP (2) JP2006505579A (pl)
KR (1) KR20050071611A (pl)
CN (1) CN1703198A (pl)
AR (1) AR041826A1 (pl)
AU (1) AU2003267763A1 (pl)
BR (1) BR0315663A (pl)
CA (1) CA2498276A1 (pl)
GT (1) GT200300227A (pl)
MX (1) MXPA05004299A (pl)
NL (1) NL1024616C (pl)
NO (1) NO20051187L (pl)
PA (1) PA8586301A1 (pl)
PE (1) PE20040471A1 (pl)
PL (1) PL375603A1 (pl)
RU (1) RU2292207C2 (pl)
TW (1) TW200418477A (pl)
UY (1) UY28035A1 (pl)
WO (1) WO2004037224A1 (pl)
ZA (1) ZA200501979B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
DE60327225D1 (de) 2002-08-20 2009-05-28 Bristol Myers Squibb Co Aripiprazol-komplex-formulierung und verfahren
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
CA2525868A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Anxiety treatments with ziprasidone
WO2006000913A1 (en) * 2004-06-23 2006-01-05 Pfizer Products Inc. Method for sterile filtration of viscous pharmaceutical compositions
BRPI0515372B8 (pt) * 2004-09-17 2021-05-25 Durect Corp composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico
US20080254114A1 (en) * 2005-03-03 2008-10-16 Elan Corporation Plc Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
CN100391458C (zh) * 2006-02-07 2008-06-04 上海医药工业研究院 齐拉西酮或其盐包合物制备方法
MX2008014283A (es) * 2006-05-09 2008-11-18 Astrazeneca Ab Formulacion parental la cual comprende un inhibidor de bomba de protones esterilizado en su recipiente final por radiacion de ionizacion.
PL2117521T3 (pl) 2006-11-03 2012-11-30 Durect Corp Transdermalne systemy dostarczania zawierające bupiwakainę
WO2009075782A1 (en) * 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US12274794B2 (en) 2016-07-06 2025-04-15 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
WO2018153315A1 (zh) 2017-02-23 2018-08-30 上海华汇拓医药科技有限公司 一种多奈哌齐半帕莫酸盐的粉针剂、包含其的组合物及它们的制备方法
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CN116940358A (zh) 2021-01-12 2023-10-24 度勒科特公司 持续释放药物递送系统和有关的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002265A1 (fr) * 1987-09-07 1989-03-23 Teijin Limited Emulsion grasse contenant un medicament, du type prepare immediatement avant l'utilisation, et procede de preparation d'une telle emulsion grasse contenant un medicament
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
JP3954115B2 (ja) * 1992-07-28 2007-08-08 アストラゼネカ・アクチエボラーグ 注射剤および注射剤キット
US5594141A (en) * 1994-11-23 1997-01-14 Neurogen Corporation Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
UA57734C2 (uk) * 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
DK0811386T3 (da) * 1996-05-07 2005-01-03 Pfizer Fremgangsmåde til udvælgelse af et salt til fremstilling af et inklusionskompleks
JP2002512597A (ja) * 1996-12-20 2002-04-23 アルザ コーポレイション 注射可能な貯留槽ゲル組成物およびこの組成物の製造方法
KR20010012374A (ko) * 1997-05-16 2001-02-15 스티븐 엠. 오드레 지속 효과를 갖는 서방성 겔
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
PL196867B1 (pl) * 1999-05-27 2008-02-29 Pfizer Prod Inc Kompozycja zyprazydonu
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
JP4334229B2 (ja) * 2001-03-20 2009-09-30 サイデックス・ファーマシューティカルズ・インコーポレイテッド プロポフォール及びスルホアルキルエーテルシクロデキストリン含有製剤
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
IL160306A0 (en) * 2001-08-31 2004-07-25 Univ Rockefeller Method for classification of anti-psychotic drugs

Also Published As

Publication number Publication date
PE20040471A1 (es) 2004-08-14
RU2292207C2 (ru) 2007-01-27
AU2003267763A1 (en) 2004-05-13
UY28035A1 (es) 2004-05-31
CN1703198A (zh) 2005-11-30
KR20050071611A (ko) 2005-07-07
NL1024616C (nl) 2010-04-19
AR041826A1 (es) 2005-06-01
BR0315663A (pt) 2005-08-30
MXPA05004299A (es) 2005-08-03
US20040146562A1 (en) 2004-07-29
NL1024616A1 (nl) 2004-04-27
CA2498276A1 (en) 2004-05-06
NO20051187L (no) 2005-04-11
ZA200501979B (en) 2006-04-26
JP2006219501A (ja) 2006-08-24
WO2004037224A1 (en) 2004-05-06
EP1562546A1 (en) 2005-08-17
TW200418477A (en) 2004-10-01
RU2005112202A (ru) 2005-11-20
JP2006505579A (ja) 2006-02-16
PA8586301A1 (es) 2004-05-07
GT200300227A (es) 2004-06-23

Similar Documents

Publication Publication Date Title
PL370501A1 (pl) Mieszaniny analogów cyklosporyny i ich zastosowanie jako środków immunomodulujących
EP1313470A4 (en) NEW ALICYCLIC IMIDAZOLE AS H 3 ACTIVE SUBSTANCES
AU2003298738A8 (en) Liposomal formulations
IL152514A0 (en) Fungicidal combinations of active agents
AU2003285346A8 (en) Regulatory elements in the 5' region of the vr1 gene
GB0012775D0 (en) Agrochemical suspension formulations
AU2003298083A1 (en) Detergent in the form of mould elastic body
AU2003302320A8 (en) Seterocyclic quinones as pharmaceutical agents
AU2002361181A8 (en) Shaped body containing agents with increased storage stability
AU2003291757A8 (en) Formulations of low solubility bioactive agents and processes for making the same
GB0214147D0 (en) Formulations
PH12003501081B1 (en) Insecticidal composition having improved storage stability
GB0103354D0 (en) Biologically active agents
AU143729S (en) Spray caddy
AU143730S (en) Spray caddy
AU148305S (en) Spray caddy
TW499904U (en) Improved structure of storage frame
GB0010760D0 (en) Top of the class-board game
ZA200304306B (en) "Provision of graphic designs".
GB0115562D0 (en) None given on form 1/77
PL352618A1 (pl) Kamiesigma jubilerski
GB0201314D0 (en) Dice 100 game
TW419959U (en) Structure of the shoe model head with elasticity
GB0127289D0 (en) 2 in 1 flask
GB0011473D0 (en) The climbers bed

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)